Elutia Corp (ELUT): Debts to Book Capitalization

Brandmark of Elutia Inc (ELUT)

By adhering to environmental bio-waste disposal regulations, Elutia Inc. demonstrates a minimal carbon footprint. The distribution of debt capital within the balance sheet capitalization, as reflected in GURU.Markets quotes, is characterized by the fact that the 0.74 indicator expresses the state of the metric. The issuer dominates the regenerative medicine sector thanks to CanGaroo antibacterial shells, while generating profit from the sale of bio-implants and surgical drug delivery systems.

ELUT (Elutia Corporation) Debt to Book Value history from 02/21/2024 to 10/27/2026
Original product of Elutia Corporation

The credit quality of the business is determined by the balance between borrowed funds and equity. This metric measures the proportion of liabilities to the total book value of assets, allowing for an assessment of financial stability and the risk of over-leverage. For Elutia Inc. (ELUT), the stability of the liability structure confirms the ability to maintain a costly staff of R&D engineers without excessive debt pressure. An analysis of the company's debt-to-book capitalization reveals the actual dynamics of financial leverage, while this chart filters the trend from market noise.

Who Elutia Inc. competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Milestone Scientific (MLSS)|nexgel.com - Debt to Book Capital|Debt to Book Capitalization Ratio RVP (Retractable Tech)|HBIO - Debts to Net Assets|Debts to Book Capitalization FEMY|MHUA (Meihua Medical Technologies Co., Ltd.) - Debts to Book Value|Debt to Book Capitalization Ratio Predictive Oncology Inc|Debt to Book Capitalization Ratio Callan JMB Corp (CJMB)|Debt to Book Value ATRI|Debts to Book Capitalization NeuroMetrix Inc NURO